Name: Sionna Therapeutics, Inc. (SION) Balance Sheet
Creator: FinSpry

Sionna Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Sionna Therapeutics, Inc. (SION) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	37.79	38.52	54.84
Short-Term Investments	109.75	0.00	27.77
Cash & Short-Term Investments	147.54	38.52	82.61
Accounts Receivable	0.00	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	3.46	0.69	1.22
Total Current Assets	150.99	39.21	83.83
Non-Current Assets
Property, Plant & Equipment (Net)	10.30	11.62	1.79
Long-Term Investments	20.51	0.00	0.00
Other Non-Current Assets	3.96	1.12	1.74
Total Non-Current Assets	34.76	12.74	3.54
Total Assets	185.75	51.95	87.37
Current Liabilities
Accounts Payable	1.19	0.72	0.56
Short-Term Debt	1.07	0.00	0.00
Accrued Liabilities	7.67	6.59	7.70
Other Current Liabilities	0.49	0.00	0.00
Total Current Liabilities	10.42	8.04	8.25
Non-Current Liabilities
Long-Term Debt	8.68	9.75	0.00
Other Non-Current Liabilities	330.37	0.00	0.00
Total Non-Current Liabilities	339.05	158.79	149.04
Total Liabilities	19.10	17.79	8.25
Stockholders' Equity
Common Stock	0.01	0.00	0.00
Retained Earnings	-181.09	-119.40	-72.14
Accumulated Other Comprehensive Income	0.37	0.00	-0.02
Additional Paid-in Capital	17.00	4.52	2.23
Shares Outstanding	42.44	42.44	42.44
Total Stockholders' Equity	166.66	34.16	79.12
Total Liabilities & Equity	185.75	51.95	87.37